Stocks Health care BHVN
NYSE · Health careBiohaven Ltd. (BHVN)
It posted a net loss of $586.8M. In fiscal 2025 capital spending exceeded operating cash flow by $610.2M. At June 30, 2026 it held $238M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 10, 2026.
What Biohaven Ltd. does
Biohaven Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker BHVN.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$738.8M | -$6.86 | -$610.2M |
| 2024 | n/a | -$846.4M | -$9.28 | -$586.5M |
| 2023 | n/a | -$408.2M | -$5.73 | -$334.8M |
| 2022 | n/a | -$570.3M | -$12.75 | -$303.8M |
| 2022 | n/a | -$213.8M | -$5.43 | -$146.8M |
| 2020 | n/a | -$118.7M | -$3.01 | -$77.1M |
Latest SEC filings
What Biohaven Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026Other event 8-K
- August 26, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 10, 2026
- August 10, 2026Quarterly report 10-Q · period to June 30, 2026
- August 7, 2026
- July 9, 2026
- July 8, 2026Passive stake changed SCHEDULE 13G/A
- May 27, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about BHVN
What does Biohaven Ltd. do?
Biohaven Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NYSE under the ticker BHVN.
Is Biohaven Ltd. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $586.8M.
When did Biohaven Ltd. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 10, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 17, 2026.
Similar companies
Follow BHVN
Get an email when Biohaven Ltd. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BHVN: get an email when it filesWhere the numbers come from
Financial figures are the values Biohaven Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.